Literature DB >> 21080234

Presence of apolipoprotein C-III attenuates apolipoprotein E-mediated cellular uptake of cholesterol-containing lipid particles by HepG2 cells.

Shin-ya Morita1, Atsushi Sakurai, Minoru Nakano, Shuji Kitagawa, Tetsurou Handa.   

Abstract

Apolipoprotein C-III (apoC-III) decreases the apolipoprotein E (apoE)-mediated uptake of lipoprotein remnants by the liver, and a high plasma concentration of apoC-III in VLDL is associated with hypertriglyceridemia and the risk of coronary heart disease. In this study, we prepared lipid emulsions containing triolein, phosphatidylcholine and cholesterol as model particles of lipoproteins, and examined the roles of apoC-III in apoE-mediated uptake of emulsions by HepG2 cells. Cholesterol in emulsion particles enhanced the apoE-mediated uptake via heparan sulfate proteoglycan and LDL receptor-related protein pathways. The amount of apoE bound to emulsion particles was increased by the presence of cholesterol at the particle surface, whereas cholesterol had no effect on the binding amount of apoC-III. Surface cholesterol alleviated the inhibitory effect of apoC-III on apoE incorporation into the emulsion surface. However, ApoC-III almost completely inhibited the apoE-mediated uptake of cholesterol-containing emulsions despite sufficient binding of apoE to emulsions. These findings suggest that apoC-III attenuates the binding of apoE to the lipoprotein surface and apoE-mediated cellular uptake of lipoprotein remnants. Furthermore, cholesterol may affect these functions of apoC-III and apoE involved in the clearance of lipoprotein remnants.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080234     DOI: 10.1007/s11745-010-3498-9

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  56 in total

1.  Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.

Authors:  R Batal; M Tremblay; P H Barrett; H Jacques; A Fredenrich; O Mamer; J Davignon; J S Cohn
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

2.  Role of leucine zipper motif in apoE3 N-terminal domain lipid binding activity.

Authors:  Taichi Yamamoto; Robert O Ryan
Journal:  Biochim Biophys Acta       Date:  2006-07-21

Review 3.  Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.

Authors:  R W Mahley; Z S Ji
Journal:  J Lipid Res       Date:  1999-01       Impact factor: 5.922

4.  Characterization of the heparin binding sites in human apolipoprotein E.

Authors:  Hiroyuki Saito; Padmaja Dhanasekaran; David Nguyen; Faye Baldwin; Karl H Weisgraber; Suzanne Wehrli; Michael C Phillips; Sissel Lund-Katz
Journal:  J Biol Chem       Date:  2003-02-14       Impact factor: 5.157

5.  Atherogenicity of triglyceride-rich lipoproteins.

Authors:  R M Krauss
Journal:  Am J Cardiol       Date:  1998-02-26       Impact factor: 2.778

6.  Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.

Authors:  R C Kowal; J Herz; K H Weisgraber; R W Mahley; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

7.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

Authors:  S H Zhang; R L Reddick; J A Piedrahita; N Maeda
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

8.  Ceramide in lipid particles enhances heparan sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages.

Authors:  Shin-Ya Morita; Misa Kawabe; Atsushi Sakurai; Keiichirou Okuhira; Aline Vertut-Doï; Minoru Nakano; Tetsurou Handa
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

9.  A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity.

Authors:  Arun Sivashanmugam; Jianjun Wang
Journal:  J Biol Chem       Date:  2009-03-23       Impact factor: 5.157

10.  Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG.

Authors:  Z S Ji; R W Mahley
Journal:  Arterioscler Thromb       Date:  1994-12
View more
  3 in total

1.  Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes.

Authors:  Juraj Koska; Hussein Yassine; Olgica Trenchevska; Shripad Sinari; Dawn C Schwenke; Frances T Yen; Dean Billheimer; Randall W Nelson; Dobrin Nedelkov; Peter D Reaven
Journal:  J Lipid Res       Date:  2016-03-03       Impact factor: 5.922

2.  APOC3 induces endothelial dysfunction through TNF-α and JAM-1.

Authors:  Yun Tao; Yisong Xiong; Huimin Wang; Shaopeng Chu; Renqian Zhong; Jianxin Wang; Guihua Wang; Xiumei Ren; Juan Yu
Journal:  Lipids Health Dis       Date:  2016-09-13       Impact factor: 3.876

3.  A Novel Y-Specific Long Non-Coding RNA Associated with Cellular Lipid Accumulation in HepG2 cells and Atherosclerosis-related Genes.

Authors:  Elsa Molina; Guat S Chew; Stephen A Myers; Elyse M Clarence; James M Eales; Maciej Tomaszewski; Fadi J Charchar
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.